Global meat market continues to grow,
be our trusted partner
That’s $1.7 trillion today and $2.7 trillion in 2050 at current prices
HUGE OPPORTUNITY
Are you with us?
TRUSTED PARTNERSHIP OPPORTUNITY
Meatable technology will be licensed to meat industry partners, who can acquire specific territory rights, with royalties reinvested into rapidly optimizing and diversifying our technology, not assets
Asset-light, pure-licensing model
Funds only invested in tech optimization:
- Highly scalable, no plant capex
- No stranded / outdated assets
- Near-term and ongoing revenues through licensing
- High margin
Partner to the meat industry
Friend, not competitor to the meat industry:
- Solves industry challenges
- Fills a product gap in claims-based products
- Fits with existing meat value chain
Turnkey solution
Full partner package:
- Full process design
- Approved list of sourcing partners
- Help with product formulation consumer studies
- Tech transfer support to develop plant sites
IP-protected tech that works
Unique, patented technology that delivers quality product at cost
- Patented and scalable
- Traceable and protectable IP
- Translatable to multiple products (e.g. beef, leather)
GLOBAL MEATABLE OPPORTUNITY
Demand growth for meat of +70% to 2050; current livestock production already has a devastating impact on the planet and society
Continuation of current livestock-based production to the protein gap will make the situation worse – we can help solve society’s challenges by providing a better alternative
Meatable’s cutting edge proprietary science and technology produces meat faster and more efficiently than the livestock-based meat industry, without harming people, animals, or the planet
Meatable owns the field’s leading technology, opti-ox™: the only method to differentiate pluripotent stem cells (PSCs) to muscle and fat cells at speed, and 100% efficiency
We have achieved 90% flavour similarity to livestock-based pork fat; consumers and chefs buy into the product
Meatable technology will be licensed to industry partners. Royalties are reinvested into rapidly optimizing and diversifying our technology, not assets.
Clearly defined commercialization plan to address the $4.1B market activates 7 commercialization hubs across the globe.
Led by a world-leading team, funds will be used to reach price parity, derisk industry-scale production and obtain regulatory approvals to drive commercial rollout
